Tirzepatide, a novel, dual glucose-dependent insulinotropic polypeptide/glucagon-like peptide-1 receptor agonist for the ongoing diabesity epidemic: the dawn of a new era?
Article in Expert Review of Clinical Pharmacology (October 2024)
The most recent citing publications are shown below. View all 5 publications that cite this research output on Dimensions.
Article in Expert Review of Clinical Pharmacology (October 2024)
Article in JAMA Network Open (September 2024)
Article in Nature (September 2024)